Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.32
    OpenPayerPolicy UpdatesPsychiatry/Behavioral HealthColorado DOI nonpharmacological opioid coverage | …
    Ask Trek AI about this page
    CurrentColorado Division of InsurancePolicy N/A

    Coverage for nonpharmacological alternatives to opioids and atypical opioid access

    Customize your policy alerts

    Sign up for all Colorado Division of Insurance policy alerts

    Know when Colorado Division of Insurance releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    State law specifying required health plan coverage and prescribing rules in Colorado, affecting health benefit plans, prescribers, and insurers operating in Colorado. It mandates coverage of certain nonpharmacological therapies, formulary placement and access rules for atypical opioids, PDMP queries, and prescribing limits for opioids and benzodiazepines.

    Policy Summary
    PayerColorado Division of Insurance
    PolicyCoverage for nonpharmacological alternatives to opioids and atypical opioid access
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateJan 1, 2020
    Next Review DateN/A
    Key ActionDo not require prior authorization for mandated nonpharmacological alternative treatments and ensure at least one FDA‑approved atypical opioid is on the lowest formulary tier without step therapy.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    6minimum covered visits per therapy type (PT/OT/chiropractic/acupuncture)
    no prior authorizationrequired for nonpharmacological alternatives
    ≥1atypical opioid lowest formulary tier

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    7 days
    initial opioid prescription supply limit
    2nd fillPDMP query before second fill

    Coverage Criteria

    Nonpharmacological Alternative Coverage

    Covered when the carrier provides health benefit plan coverage in Colorado:

    Mandatory coverage for nonpharmacological alternatives: Any health benefit plan, except supplemental policies covering a specified disease or other limited benefit, must provide coverage for nonpharmacological treatment as an alternative to opioids.
    Minimum visit coverage: Coverage must include, at a cost-sharing amount not to exceed the cost-sharing amount for a primary care visit for nonpreventive services, a minimum of six physical therapy visits, six occupational therapy visits, six chiropractic visits, and six acupuncture visits.6 visits each

    Cost-sharing capped at primary care nonpreventive visit level.

    Prior authorization prohibition: Nonpharmacological treatments as an alternative to opioids shall not require prior authorization, as defined in statute.

    Prior authorization defined in separate statute (section 10-16-112.5).

    Atypical Opioid Coverage

    Prescription drug coverage requirements:

    Atypical opioid formulary placement: A carrier that provides prescription drug benefits must provide coverage for at least one atypical opioid approved by the FDA for acute or chronic pain at the lowest tier of the carrier's drug formulary.at least one drug
    No step therapy or prior authorization for atypical opioids: The carrier must not require step therapy or prior authorization for that atypical opioid, and must not require step therapy for any additional FDA-approved atypical opioids for acute or chronic pain.

    Opioid and Benzodiazepine Prescribing Rules

    Prescribing limits and exceptions:

    Initial opioid supply limit: A prescriber shall not prescribe more than a seven-day supply of an opioid to a patient who has not had an opioid prescription in the last twelve months by that prescriber, with discretion to include a second fill for a seven-day supply based on clinical judgment and specified exceptions (e.g., chronic pain, palliative or hospice care).<= 7 days initial

    Exceptions include clinical judgment and listed care situations; see statute for prescriber types allowed in hospice exception.

    PDMP query requirement for second fill: Each practitioner or the practitioner's designee shall query the prescription drug monitoring program before prescribing a second fill for a benzodiazepine and must attempt to query before a second fill for an opioid; an attempt suffices if the program is inaccessible due to technical failure. Exceptions apply for hospice care, treatment of seizure or seizure disorder, alcohol withdrawal, or a neurological emergency event including a post‑traumatic brain injury.query before 2nd fill

    Attempts to access PDMP count if system is unavailable.

    Prescription Drug Monitoring Program

    PDMP scope and operation:

    PDMP data elements and reporting frequency: The PDMP shall track controlled substances and other prescription drugs as designated by board rule, require daily entry of prescription data, include payer name beginning January 1, 2021, and permit the board to designate additional drugs to be tracked.daily entry

    Board will promulgate rules designating additional controlled substances and other prescription drugs to be tracked.

    Supplemental limited-benefit policies are excluded from the mandate requiring coverage of nonpharmacological treatments. Specifically, the statute states that any health benefit plan must provide coverage for nonpharmacological treatment as an alternative to opioids, except supplemental policies covering a specified disease or other limited benefit.

    Providers may inform covered persons about their financial responsibility for services; the law prohibits restricting a physical therapist, occupational therapist, or acupuncturist from providing a covered person information on the amount of the covered person’s financial responsibility for those services.

    Provider Actions and Requirements

    Prior Authorization

    No prior authorization for nonpharmacological alternatives; atypical opioid access

    Nonpharmacological treatments required by Colorado law shall not be subject to prior authorization; carriers must also place at least one FDA‑approved atypical opioid for acute or chronic pain on the lowest formulary tier without requiring prior authorization.

    • Nonpharmacological treatments as alternatives to opioids shall not require prior authorization.
    • A carrier providing prescription drug benefits must provide coverage for at least one FDA‑approved atypical opioid at the lowest formulary tier and not require prior authorization for that atypical opioid.
    Step Therapy

    Step therapy prohibited for atypical opioids

    Carriers are prohibited from requiring step therapy for at least one FDA‑approved atypical opioid placed on the lowest formulary tier and may not impose step therapy for any additional FDA‑approved atypical opioids for acute or chronic pain.

    • Do not implement step therapy as a condition of coverage for the required atypical opioid on the lowest tier.

    Background

    The act recognizes the opioid epidemic and promotes safer alternatives by requiring coverage for specified nonpharmacological therapies and by directing carrier formulary policies for certain lower-risk analgesics. It identifies examples of atypical opioids such as buprenorphine, tramadol, and tapentadol as alternatives with different safety profiles, and mandates access and protections (for example, minimum covered visits and prohibition of prior authorization for nonpharmacological treatments) to encourage use of these alternatives.

    Definitions

    inv-12: Atypical opioid
    Definition"Atypical opioid" means a nonopioid analgesic with far lower fatality rates than pure opioid agonists; examples referenced include buprenorphine, tramadol, and tapentadol.
    Formulary requirementCarrier must provide coverage for at least one FDA‑approved atypical opioid for acute or chronic pain at the lowest tier of the drug formulary.
    Utilization controls prohibitedCarrier must not require step therapy or prior authorization for that atypical opioid; no step therapy may be required for any additional FDA‑approved atypical opioids for acute or chronic pain.
    inv-13: PDMP query exceptions for benzodiazepines
    General PDMP requirementEach practitioner or the practitioner’s designee shall query the program before prescribing a second fill for a benzodiazepine.
    Hospice exception

    Treatment Modalities

    Nonpharmacological therapies (PT, OT, chiropractic, acupuncture)

    Coverage criteria for nonpharmacological therapies:

    Minimum visits for modality: Minimum of six visits covered at cost-sharing not to exceed primary care nonpreventive visit level.6 visits

    Applies to physical therapy, occupational therapy, chiropractic, acupuncture.

    Atypical opioids (buprenorphine, tramadol, tapentadol)

    Coverage and placement for atypical opioids:

    Atypical opioids identified: Examples referenced include buprenorphine, tramadol, and tapentadol; these are characterized as atypical opioids and the carrier's obligations apply to FDA‑approved atypical opioids for acute or chronic pain.

    Visit Minimums and Limits

    inv-16: Physical therapy visits (minimum)
    Minimum visits6 physical therapy visits must be covered at cost‑sharing not to exceed the cost‑sharing for a primary care nonpreventive visit.
    Cost‑sharing capCost‑sharing for these visits may not exceed the cost‑sharing amount for a primary care visit for nonpreventive services.
    Prior authorizationCoverage for these physical therapy visits shall not require prior authorization when provided as an alternative to opioids.
    inv-17: Occupational therapy visits (minimum)
    Minimum visits6 occupational therapy visits must be covered at cost‑sharing not to exceed the cost‑sharing for a primary care nonpreventive visit.
    Cost‑sharing capCost‑sharing for these visits may not exceed the cost‑sharing amount for a primary care visit for nonpreventive services.
    Policy Summary
    PayerColorado Division of Insurance
    PolicyCoverage for nonpharmacological alternatives to opioids and atypical opioid access
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateJan 1, 2020
    Next Review DateN/A
    Key ActionDo not require prior authorization for mandated nonpharmacological alternative treatments and ensure at least one FDA‑approved atypical opioid is on the lowest formulary tier without step therapy.
    SourceLink
    On This Page
    Coverage CriteriaProvider Actions and RequirementsBackgroundDefinitionsTreatment ModalitiesVisit Minimums and Limits
  1. Do not require step therapy for any additional FDA‑approved atypical opioids for acute or chronic pain.
  2. Documentation Required

    Notify carrier at patient’s initial visit

    At the covered person's initial visit, the treating physical therapist, occupational therapist, acupuncturist, or chiropractor must notify the covered person's carrier that the patient has started treatment with that provider.

    • Notification must occur at the time of the covered person's initial visit for treatment.
    Denial Risk

    Coverage and prior authorization prohibitions — carrier obligations and enforcement risk

    Failure to provide the mandated coverage and to avoid prior authorization or step therapy as required by statute may expose carriers to enforcement; carriers must provide coverage for the specified nonpharmacological services and comply with the statutory prohibitions on prior authorization and step therapy.

    • Carriers must provide coverage for nonpharmacological treatments (minimum six visits per modality) and must not require prior authorization for those treatments.
    • Carriers providing prescription drug benefits must place at least one FDA‑approved atypical opioid on the lowest formulary tier and must not impose step therapy or prior authorization for that drug (nor step therapy for additional atypical opioids).
    No PDMP query required if the benzodiazepine is prescribed to treat a patient in hospice.
    Seizure disorder exceptionNo PDMP query required when the benzodiazepine is prescribed to treat a seizure or seizure disorder.
    Alcohol withdrawal exceptionNo PDMP query required when the benzodiazepine is prescribed to treat alcohol withdrawal.
    Neurological emergency exceptionNo PDMP query required when the benzodiazepine is prescribed for a neurological emergency event, including a post‑traumatic brain injury.
    Formulary and utilization protections:
    At least one FDA‑approved atypical opioid for acute or chronic pain must be placed on the lowest formulary tier and must not be subject to step therapy or prior authorization; carriers also shall not require step therapy for any additional FDA‑approved atypical opioids for acute or chronic pain.
    at least one drug
    Prior authorizationCoverage for these occupational therapy visits shall not require prior authorization when provided as an alternative to opioids.
    inv-18: Chiropractic visits (minimum)
    Minimum visits6 chiropractic visits must be covered at cost‑sharing not to exceed the cost‑sharing for a primary care nonpreventive visit.
    Cost‑sharing capCost‑sharing for these visits may not exceed the cost‑sharing amount for a primary care visit for nonpreventive services.
    Prior authorizationCoverage for these chiropractic visits shall not require prior authorization when provided as an alternative to opioids.
    inv-19: Acupuncture visits (minimum)
    Minimum visits6 acupuncture visits must be covered at cost‑sharing not to exceed the cost‑sharing for a primary care nonpreventive visit.
    Cost‑sharing capCost‑sharing for these visits may not exceed the cost‑sharing amount for a primary care visit for nonpreventive services.
    Prior authorizationCoverage for these acupuncture visits shall not require prior authorization when provided as an alternative to opioids.